Question

Difficulty: HardMonitoring and Treatment Evaluation

A 58-year-old woman is brought to the emergency department by her husband due to a 3-day history of increasing confusion, sluggishness, and tremors. Her husband reports that she has been sleeping more than usual and has had difficulty holding a glass of water without spilling it. Her medical history is significant for bipolar I disorder, for which she has been stable on lithium carbonate 900 mg daily for the past 5 years. She also has osteoarthritis and began taking naproxen 500 mg twice daily two weeks ago for worsening knee pain.

On physical examination, temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, pulse is 88/min, and respirations are 14/min. She appears lethargic but is easily arousable. Neurologic examination reveals a prominent coarse, irregular tremor in her upper extremities bilaterally, as well as hyperreflexia in all four extremities. No nuchal rigidity is noted.

Serial laboratory studies are shown below:

Parameter2 Weeks AgoToday
Blood urea nitrogen14 mg/dL32 mg/dL
Serum creatinine0.9 mg/dL1.6 mg/dL
Serum lithium0.8 mEq/L2.1 mEq/L
Serum sodium140 mEq/L138 mEq/L
Serum potassium4.0 mEq/L4.2 mEq/L

An electrocardiogram shows normal sinus rhythm with no ST-segment or T-wave abnormalities.

Which of the following is the most appropriate next step in the management of this patient?

  1. Discontinue lithium and naproxen, and administer intravenous isotonic salineAnswer
  2. B
    Discontinue lithium and naproxen, and initiate emergency hemodialysis
  3. C
    Administer oral activated charcoal and discontinue naproxen
  4. D
    Discontinue lithium and administer intravenous furosemide
  5. E
    Discontinue naproxen, decrease the lithium dose by 50%, and observe

Answer

Discontinue lithium and naproxen, and administer intravenous isotonic saline
This patient is experiencing acute-on-chronic lithium toxicity, precipitated by the addition of naproxen. NSAIDs inhibit renal prostaglandin synthesis, leading to afferent arteriolar vasoconstriction, decreased glomerular filtration rate (GFR), and a compensatory increase in the proximal tubular reabsorption of sodium and lithium. Her clinical presentation (lethargy, coarse tremor, hyperreflexia) and acute kidney injury (creatinine 1.6 mg/dL) confirm active toxicity. For lithium levels <2.5 mEq/L< 2.5 \text{ mEq/L} without life-threatening symptoms (e.g., seizures, coma), the first-line treatment is to discontinue the offending agents and administer aggressive intravenous hydration with isotonic (0.9%) saline. Saline restores intravascular volume, improves GFR, and provides a sodium load that competitively inhibits the proximal tubular reabsorption of lithium, thereby enhancing its excretion.

Step-by-Step Solution

1
Analyze the patient's medication history and recent changes.
The patient recently started naproxen, an NSAID, while on chronic lithium therapy.
NSAIDs can precipitate lithium toxicity by inhibiting renal prostaglandin synthesis, leading to decreased afferent arteriolar blood flow, decreased GFR, and increased proximal tubular reabsorption of sodium and lithium.
2
Evaluate the clinical presentation and laboratory findings.
The patient exhibits signs of acute-on-chronic lithium toxicity (lethargy, coarse tremor, hyperreflexia) alongside an acute kidney injury (creatinine elevated to 1.6 mg/dL) and a supratherapeutic serum lithium level of 2.1 mEq/L.
Determining the severity of toxicity and current renal function is critical for selecting the appropriate treatment modality.
3
Determine the indication for hemodialysis versus intravenous hydration.
Because the lithium level is <2.5 mEq/L and the patient does not have severe life-threatening neurologic symptoms (such as seizures or coma), intravenous isotonic saline is the indicated next step rather than hemodialysis.
Isotonic saline restores intravascular volume, improves GFR, and provides a sodium load that competitively inhibits the proximal tubular reabsorption of lithium, thereby enhancing its renal excretion.

Key Concept

The initial management of symptomatic lithium toxicity with a level <2.5 mEq/L involves discontinuing the offending agents (lithium and precipitants like NSAIDs, thiazides, or ACE inhibitors) and administering aggressive intravenous hydration with isotonic normal saline.
Estimated Time:1m 30s
Rate this question